PATENT CLAIM ANALYSIS

Application Number: 15974171
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "351000"]

Abstract:
Disclosed are novel compounds having the structure of Formula (I): which are useful for treating mammals for dependence upon substances of addiction, for example addiction to a dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and/or alcohol. Also disclosed are pharmaceutical compositions comprising a therapeutically effective amount of a compound of Formula (I) and methods of using the compounds of Formula (I) in the treatment of addiction to a dopamine-producing agent.

Claim (Index 3):
The compound of  claim 1 , wherein R 2  is hydrogen, C 1-6  alkyl, or halo.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 93.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15476569', '14659042', '13537536', '13966029', '13791422']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8040991928681976
- 35 USC 102 Novelty (BERT): 0.586560086190236
- Combined Prediction Score: 0.7823452822004016
- Mean Citation Score: 451.44146
- Max Citation Score: 464.60397
- Similarity Product: 460.3256918558049

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test